awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35537385-5E14E287-6F00-4053-BFD8-2996BFF00930
Q35537385-5E14E287-6F00-4053-BFD8-2996BFF00930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35537385-5E14E287-6F00-4053-BFD8-2996BFF00930
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
P2860
Q35537385-5E14E287-6F00-4053-BFD8-2996BFF00930
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35537385-5E14E287-6F00-4053-BFD8-2996BFF00930
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ac433e12e2715446fc7a5e5fd4f8af7b59b106a5
P2860
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.